CClinicalTrials.gg
TerminatedNCT06399094ATF/SPPUpdated Nov 17, 2025

Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)

An observational study in Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease and Cystic Fibrosis, sponsored by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace. Terminated at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-17.

Sponsored by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · Observational

Why this study was terminated
Recruitment issue
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
23
Ages
18 Years and older
Sex
All
01

Study summary

The main objective of the study is to assess the potential of time-frequency representation and analysis of pulmonary sounds collected with an electronic stethoscope, as part of the routine monitoring of patients with cystic fibrosis, COPD or pulmonary fibrosis.

Read the detailed description

Secondary objectives

The other objectives of this study are :

  1. To evaluate the ability to detect changes in lung sounds, following optimization of the time-frequency representation.
  2. To evaluate the ability to quantify differences in the severity of the pathological sounds detected using artificial intelligence and a supervised learning method.

Conduct of research This is a single-center, non-randomized, open-label study involving 60 male and female patients aged 18 to 65, eligible for a scheduled consultation as part of their usual pathological follow-up (routine care).

Lung sound recordings will be made during the same consultation, after obtaining the patient's non-opposition.

Recordings will be made using a 3M Littmann© model 3200 electronic stethoscope. The stethoscope works with Eko software, which will be installed on a touch-sensitive tablet or computer, enabling local storage of recorded data.

Whatever the patient's pathology, the physician will listen to 10 lung sites defined in the protocol. At least one breath per pulmonary site will be recorded during the consultation.

If a patient comes back for a consultation before the end of the recruitment period, a new lung sound recording will be performed.

02

Conditions studied

  • Pulmonary Fibrosis
  • Chronic Obstructive Pulmonary Disease
  • Cystic Fibrosis
03

In context

Pulmonary Fibrosis

680 studies on the registry are indexed under Pulmonary Fibrosis; 119 are open to participants now.

This study's enrollment of 23 is below the median of 130 across 229 observational studies indexed under Pulmonary Fibrosis.

Browse Pulmonary Fibrosis studies →

Lead sponsor

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace is the lead sponsor of 27 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Eligible patients will be recruited during a consultation scheduled as part of the usual follow-up of their pathology in the pneumology department of mulhouse hospital center and strasbourg university hospital center.

Inclusion criteria

  • Age ≥ 18 years
  • Suffering from one of the following pathologies: cystic fibrosis, pulmonary fibrosis, COPD
  • Not opposed to participating in the study

Exclusion criteria

Exclusion Criteria:

  • Person under court protection, guardianship or curatorship
  • Person deprived of liberty by judicial or administrative decision
  • Patient with a history of thoracic surgery, thoracic deformity, heart failure or other relevant illness at the investigator's discretion.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
23 participants (actual)
Patient registry
No

Groups and cohorts

  • Pulmonary fibrosis

    Other: Lung sound recordings

  • Chronic Obstructive Pulmonary Disease

    Other: Lung sound recordings

  • Cystic fibrosis

    Other: Lung sound recordings

Interventions

  • OtherLung sound recordings

    The lung sound recordings will be made during a consultation scheduled as part of the patient's usual follow-up, after obtaining the patient's non-opposition.

06

What researchers measure

Primary outcomes

  1. Lung sounds visible in their representation as time-frequency images

    Pulmonary sounds will be recorded with an electronic stethoscope at each scheduled visit and processed with artificial intelligence using a supervised learning method.

    Time frame: At inclusion

Secondary outcomes

  1. Classification of sounds by severity

    Pulmonary sounds will be recorded with an electronic stethoscope at each scheduled visit and processed with artificial intelligence using a supervised learning method.

    Time frame: At inclusion

07

Study locations

2 sites
  • Hôpitaux Universitaire de Strasbourg
    Strasbourg, Bas-Rhin 67000, France
  • GHRMSA - Hôpital Emile Muller
    Mulhouse, Haut-Rhin 68100, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06399094
Lead sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Responsible party
Sponsor
First posted
May 3, 2024
Start date
Jul 18, 2024
Primary completion
Aug 30, 2025
Completion
Aug 30, 2025
Last update
Nov 17, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion